Highly professional expert team and modern production plant make POLYSAN an attractive partner for international pharmaceutical companies

FULL CYCLE OF FINISHED DOSAGE FORM PRODUCTION WITH POSSIBILITY OF API LOCALIZATION

API synthesis localization

Operating production lines

Quality Control and Assurance

Contract manufacturing is implemented in the following key directions: production of tablets, capsules, infusion solutions and solutions for intravenous and intramuscular administration.

POSSIBILITY OF ORGANIZING PRODUCTION LINE FROM SCRATCH AS PER CUSTOMER REQUIREMENTS

Setting up of various dosage forms production at 1,800 m2 manufacturing areas.

Learn more

ADVANTAGES OF CONTRACT MANUFACTURING AT POLYSAN PHARMACEUTICAL PLANT

QUALITY

Integrated Pharmaceutical Quality System designed and maintained in accordance with current EU GMP, ISO 14001, and ISO 45001 regulations.
The Quality System is updated within the frameworks of continuous change analysis of external requirements, taking into account legislative and advisory regulations such as PIC/S, PDA, FDA, ISPE, and ICH.

PRODUCTION

Full Cycle of finished dosage forms production with possibility of API localization.
High automation level, reliability, safety, and quality guarantees for manufactured products.
Organizing production from scratch as per customer requirements.
Modern production plant compliant with International and Russian GMP regulations.

EXPERIENCE IN IMPLEMENTING LOCALIZATION PROJECTS

Since 2015 POLYSAN has been vigorously developing Contract Manufacturing direction. Over the years of cooperation POLYSAN has formed mutually beneficial partnerships with the leading global pharmaceutical companies, such as Bayer, Pfizer, and NIZHPHARM.

Pfizer
Bayer

2014
Elaborating the possibility of medicinal products localization at the request of Pfizer and Bayer

Pfizer
Bayer

2015
Signing of Strategic Partnership Agreement with Bayer and Manufacturing Agreements with Pfizer (tablets) and Bayer (contrast media products)


Bayer

2016
Signing of Manufacturing Agreement with Bayer on production of innovative anticoagulant

Bayer

2018
Start of commercial production of Bayer contrast media products

Pfizer
Bayer

2019
Start of commercial production of Bayer contrast media products and Pfizer medicinal products

Bayer

2023
Start of commercial production of Bayer anticoagulant
Зеленая стрелка

At present the following medicinal products are produced at POLYSAN plant

Bayer, AG

Pfizer, Inc.

NIZHPHARM, АО


For any information about the above-mentioned medicinal products or in case of any complaints, please contact the local representative of the marketing authorization holder, whose contact information is provided on the package or in the patient-information leaflet.

CONTRACT MANUFACTURING OF FINISHED DOSAGE FORMS AND API, CDMO

Contact us in any way convenient for you:

Свяжитесь с нами

tel.: +7 (812) 448-22-22
e-mail: info@polysan.ru

Polysan

Contacts

192102, Russia, Saint Petersburg,
Salova St., 72, Bldg. 2, Lit. A.

+ 7 812 448-22-22 info@polysan.ru

Pharmacovigilance

192102, Russia, Saint Petersburg,
Salova St., 72, Bldg. 2, Lit. A.
Pharmacovigilance group
of the Medical Department.

+ 7 812 448-22-22 safety@polysan.ru